Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance

Benzinga

Boston Scientific Corp. traded higher on Wednesday after posting better-than-expected second-quarter results and raising its full-year outlook, according to Benzinga. The medical technology giant reported second-quarter revenue of $5.06 billion, exceeding the $4.89 billion consensus estimate. Adjusted earnings reached 75 cents per share, topping both analyst and internal guidance. CEO Mike Mahoney said the quarter delivered strong revenue growth, margin expansion, and continued investment in future growth.

Transcript

00:00It's Benzinga, bringing Wall Street to Main Street.

00:02Boston Scientific traded higher on Wednesday after posting better-than-expected second-quarter results

00:07and raising its full-year outlook according to Benzinga.

00:09Medical technology giant reported second-quarter revenue of $5.06 billion,

00:13exceeding the $4.89 billion consensus estimate.

00:17Adjusted earnings reached $0.75 per share, topping both analysts and internal guidance.

00:21CEO Mike Mahoney said the quarter delivered strong revenue growth,

00:24margin expansion, and continued investment in future growth.

00:27For all things money, visit Benzinga.com.

Category

Transcript

Comments

Recommended